A class action was certified against Organigram Inc., a Health Canada-approved licensed producer of cannabis, on Friday, January 18, 2019.

Organigram hires ninja director of edibles and extraction

Organigram Holdings Inc. has added Michel Robichaud to its senior management team. Robichaud will join the Moncton-based company Jan. 30 as director of edibles and extraction.

Robichaud brings a wide breadth of experience to the company as a formally trained chemist with over 20 years of senior business leadership experience. Most recently, he had led projects of an international scope with JD Irving and has managed laboratory operations with international mining company Rio Tinto. As a black-belt-certified professional, Robichaud has led development projects fully leveraging the benefits of lean, six sigma and theory of constraint systems.

“This positon is a critical strategic pillar as it leads a team working closely with TGS Colorado, our partner in extract development,” said Denis Arsenault, chief executive officer of Organigram. “Michel’s experience and professionalism will help us ensure competitive advantage, allowing us to leverage the experience of TGS and get to market faster.

“Our recent land purchase and focus on this opportunity communicates a clear strategy on extract and edible manufacturing as it relates to the legalization of recreational marijuana. We’re ecstatic about Mr. Robichaud joining the team and feel it’s one more step in ensuring Organigram does the groundwork now to ensure full preparedness for the recreational marketplace.”

Following the recently announced expansion plans, Robichaud will lead the design, build and implementation stages of a new state-of-the-art facility for allowable edible products under what is currently being established as Canada’s recreational framework for cannabis.

About Organigram Holdings

Organigram Holdings’ wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram’s facility is located in Moncton, N.B., and the company is regulated by the access to cannabis for medical purposes regulations.